Nicotine exaggerates LPS-induced airway hyperreactivity via JNK-mediated up-regulation of toll-like receptor 4

American Journal of Respiratory Cell and Molecular Biology

Volumn 51, Issue 3, 2014, Pages 370-379

  Xu, Yuan ^a   Zhang, Yaping ^a,b   Cardell, Lars Olaf ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b XI'AN MEDICAL UNIVERSITY   (China)

Author keywords

Airway hyperreactivity; Nicotine; Smoking; Toll like receptor

Indexed keywords

AIRWAY HYPERREACTIVITY; NICOTINE; SMOKING; TOLL-LIKE RECEPTOR;

ANIMALS; BRADYKININ; CHEMOKINE CCL2; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION; LIPOPOLYSACCHARIDES; MALE; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; NICOTINE; NICOTINIC AGONISTS; RESPIRATORY MUCOSA; SMOKING; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 6; TRACHEA;

EID: 84906891625     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2013-0409OC     Document Type: Article

References (35)

1. Jedrychowski W, Flak E. Maternal smoking during pregnancy and postnatal exposure to environmental tobacco smoke as predisposition factors to acute respiratory infections. Environ Health Perspect 1997;105:302-306. (Pubitemid 27273581)
2. Lødrup Carlsen KC, Carlsen KH. Effects of maternal and early tobacco exposure on the development of asthma and airway hyperreactivity. Curr Opin Allergy Clin Immunol 2001;1:139-143.
3. Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet 2007;370:786-796. (Pubitemid 47320802)
4. Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA, Young VB, Toews GB, Curtis JL, Sundaram B, et al. Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS ONE 2011;6:e16384.
5. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783-801. (Pubitemid 43261452)
6. Yarovinsky F, Zhang D, Andersen JF, Bannenberg GL, Serhan CN, Hayden MS, Hieny S, Sutterwala FS, Flavell RA, Ghosh S, et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 2005;308:1626-1629. (Pubitemid 40807512)
7. Månsson Kvarnhammar A, Tengroth L, Adner M, Cardell LO. Innate immune receptors in human airway smooth muscle cells: activation by TLR1/2, TLR3, TLR4, TLR7 and NOD1 agonists. PLoS ONE 2013;8:e68701.
8. Larsson K, Malmberg P, Eklund A. Acute exposure to swine dust causes airway inflammation and bronchial hyperresponsiveness. Am J Ind Med 1994;25:57-58. (Pubitemid 24008025)
9. Bachar O, Adner M, Uddman R, Cardell LO. Toll-like receptor stimulation induces airway hyper-responsiveness to bradykinin, an effect mediated by JNK and NF-kappa B signaling pathways. Eur J Immunol 2004;34:1196-1207. (Pubitemid 39255999)
10. Starkhammar M, Kumlien Georén S, Swedin L, Dahlén SE, Adner M, Cardell LO. Intranasal administration of poly(I:C) and LPS in BALB/c mice induces airway hyperresponsiveness and inflammation via different pathways. PLoS ONE 2012;7:e32110.
11. Roomans GM, Vanthanouvong V, Dragomir A, Kozlova I, Wróblewski R. Effects of nicotine on intestinal and respiratory epithelium. J Submicrosc Cytol Pathol 2002;34:381-388. (Pubitemid 39662961)
12. Hümmer B, Purnama I, Hahn HL. Stimulation of submucosal glands by nicotine applied locally to the airway mucosa. Klin Wochenschr 1988;66:161-169.
13. Sopori ML, Kozak W, Savage SM, Geng Y, Kluger MJ. Nicotine-induced modulation of T Cell function: implications for inflammation and infection. Adv Exp Med Biol 1998;437:279-289.
14. Xu Y, Zhang Y, Cardell LO. Nicotine enhances murine airway contractile responses to kinin receptor agonists via activation of JNK- and PDE4-related intracellular pathways. Respir Res 2010;11:13.
15. Adner M, Rose AC, Zhang Y, Swärd K, Benson M, Uddman R, Shankley NP, Cardell LO. An assay to evaluate the long-term effects of inflammatory mediators on murine airway smooth muscle: evidence that TNFalpha up-regulates 5-HT(2A)-mediated contraction. Br J Pharmacol 2002;137:971-982. (Pubitemid 35440737)
16. Fransson M, Adner M, Erjefält J, Jansson L, Uddman R, Cardell LO. Upregulation of Toll-like receptors 2, 3 and 4 in allergic rhinitis. Respir Res 2005;6:100.
17. Phipps JC, Aronoff DM, Curtis JL, Goel D, O'Brien E, Mancuso P. Cigarette smoke exposure impairs pulmonary bacterial clearance and alveolar macrophage complement-mediated phagocytosis of Streptococcus pneumoniae. Infect Immun 2010;78:1214-1220.
18. Hardaker EL, Freeman MS, Dale N, Bahra P, Raza F, Banner KH, Poll C. Exposing rodents to a combination of tobacco smoke and lipopolysaccharide results in an exaggerated inflammatory response in the lung. Br J Pharmacol 2010;160:1985-1996.
19. Nikota JK, Stämpfli MR. Cigarette smoke-induced inflammation and respiratory host defense: insights from animal models. Pulm Pharmacol Ther 2012;25:257-262.
20. Koziol-White CJ, Damera G, Panettieri RA Jr. Targeting airway smooth muscle in airways diseases: an old concept with new twists. Expert Rev Respir Med 2011;5:767-777.
21. Cazzola M, Page CP, Calzetta L, Matera MG. Pharmacology and therapeutics of bronchodilators. Pharmacol Rev 2012;64:450-504.
22. Beasley R, Perrin K, Weatherall M, Wijesinghe M. Call for withdrawal of LABA single-therapy inhaler in asthma. Lancet 2010;376:750-751.
23. Zhang Y, Cardell LO, Edvinsson L, Xu CB. MAPK/NF-κB-dependent upregulation of kinin receptors mediates airway hyperreactivity: a new perspective for the treatment. Pharmacol Res 2013;71:9-18.
24. Bergren DR. Chronic tobacco smoke exposure increases airway sensitivity to capsaicin in awake guinea pigs. J Appl Physiol (1985) 2001;90:695-704.
25. Nojiri T, Hosoda H, Tokudome T, Miura K, Ishikane S, Kimura T, Shintani Y, Inoue M, Sawabata N, Miyazato M, et al. Atrial natriuretic peptide inhibits lipopolysaccharide-induced acute lung injury. Pulm Pharmacol Ther (In press)
26. Lee I, Dodia C, Chatterjee S, Feinstein SI, Fisher AB. Protection against LPS-induced acute lung injury by a mechanism based inhibitor of NADPH-oxidase (Type 2). Am J Physiol Lung Cell Mol Physiol 2014; 306:L635-L644.
27. Adcock IM, Caramori G. Kinase targets and inhibitors for the treatment of airway inflammatory diseases: the next generation of drugs for severe asthma and COPD? BioDrugs 2004;18:167-180. (Pubitemid 38829938)
28. Banerjee A, Koziol-White C, Panettieri R Jr. p38 MAPK inhibitors, IKK2 inhibitors, and TNFα inhibitors in COPD. Curr Opin Pharmacol 2012;12:287-292.
29. Bennett BL. c-Jun N-terminal kinase-dependent mechanisms in respiratory disease. Eur Respir J 2006;28:651-661. (Pubitemid 44794682)
30. Maes T, Bracke KR, Vermaelen KY, Demedts IK, Joos GF, Pauwels RA, Brusselle GG. Murine TLR4 is implicated in cigarette smoke-induced pulmonary inflammation. Int Arch Allergy Immunol 2006;141:354-368. (Pubitemid 44783906)
31. Ferreira DS, Annoni R, Silva LF, Buttignol M, Santos AB, Medeiros MC, Andrade LN, Yick CY, Sterk PJ, Sampaio JL, et al. Toll-like receptors 2, 3 and 4 and thymic stromal lymphopoietin expression in fatal asthma. Clin Exp Allergy 2012;42:1459-1471.
32. Lun SW, Wong CK, Ko FW, Hui DS, Lam CW. Expression and functional analysis of toll-like receptors of peripheral blood cells in asthmatic patients: implication for immunopathological mechanism in asthma. J Clin Immunol 2009;29:330-342.
33. Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A, Rayner KJ, Boyer L, Zhong R, Frazier WA, et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 2010;11:155-161.
34. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV Jr, Broxmeyer HE, Charo IF. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 1997;100:2552-2561. (Pubitemid 27514895)
35. Kubo S, Kobayashi M, Masunaga Y, Ishii H, Hirano Y, Takahashi K, Shimizu Y. Cytokine and chemokine expression in cigarette smoke-induced lung injury in guinea pigs. Eur Respir J 2005;26:993-1001. (Pubitemid 41829928)